Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

LDL-C Goal for African American Patients with CAD and Hypertension

Risk Stratification and LDL-C Targets

  • The American College of Cardiology recommends an LDL-C goal of <70 mg/dL for patients with coronary artery disease (CAD) and hypertension, with an optional more aggressive target of <55 mg/dL for those at very high risk 1, 2, 3, 4, 5
  • Patients with established CAD are classified as "very high risk" and require aggressive lipid management, with a primary recommended LDL-C goal of <70 mg/dL 1, 2, 3
  • Achieving LDL-C levels <70 mg/dL is strongly recommended for patients with multiple risk factors, such as CAD plus hypertension 3, 5

Treatment Approach for African American Patients

  • High-intensity statin therapy is recommended as first-line treatment to achieve ≥50% LDL-C reduction from baseline, according to the American Heart Association 1, 2
  • If LDL-C goal is not achieved with maximum tolerated statin dose, add ezetimibe as second-line therapy, as suggested by the American College of Cardiology 1, 5
  • If target is still not achieved, consider adding a PCSK9 inhibitor (evolocumab or alirocumab), as recommended by the European Society of Cardiology 1

Evidence Supporting Lower LDL-C Targets

  • The Journal of the American College of Cardiology reports that multiple clinical trials have demonstrated that lower LDL-C levels correlate with reduced cardiovascular events, with the PROVE IT trial showing that intensive LDL-C lowering to a median of 62 mg/dL provided greater cardiovascular protection than moderate lowering to 95 mg/dL 3
  • The European Heart Journal suggests that lower LDL-C targets are particularly important for patients with multiple risk factors, such as the combination of CAD and hypertension 3, 5

Monitoring and Follow-up

  • Regular lipid monitoring is essential to ensure targets are maintained, according to the American Heart Association 1
  • For patients with elevated triglycerides, consider using non-HDL-C as a secondary target (<100 mg/dL), as recommended by the American College of Cardiology 2, 5
  • Consider direct LDL-C measurement rather than calculated LDL-C in patients with elevated triglycerides, as suggested by the European Society of Cardiology 4

Clinical Benefits of Achieving Target LDL-C

  • The American College of Cardiology reports that attainment of LDL-C levels <70 mg/dL in very high-risk patients is associated with significantly reduced cardiovascular events 2
  • The benefits of lipid-lowering therapy are proportional to the reduction in LDL-C, according to the American Heart Association 2
  • When LDL-C is above 100 mg/dL, an adequate dose of statin therapy should achieve at least a 30% lowering of LDL-C, as recommended by the American College of Cardiology 2